Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Ironwood Pharmaceuticals, Inc. (IRWD) had Return on Equity of -18.78% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$106.51M |
|
$40.77M |
|
-- |
|
$106.51M |
|
$33.93M |
|
$72.57M |
|
$-7.40M |
|
$65.17M |
|
$65.17M |
|
$40.77M |
|
$40.77M |
|
$40.77M |
|
$40.77M |
|
$72.57M |
|
$73.02M |
|
163.45M |
|
166.69M |
|
$0.25 |
|
$0.24 |
|
| Balance Sheet Financials | |
$332.29M |
|
$3.17M |
|
$102.27M |
|
$434.57M |
|
$236.31M |
|
$385.00M |
|
$415.40M |
|
$651.71M |
|
$-217.14M |
|
$-218.98M |
|
$-217.14M |
|
164.61M |
|
| Cash Flow Statement Financials | |
$5.12M |
|
-- |
|
-- |
|
$215.46M |
|
$220.47M |
|
$5.01M |
|
$3.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.41 |
|
-- |
|
-- |
|
2.29 |
|
-2.69 |
|
100.00% |
|
68.14% |
|
68.14% |
|
-- |
|
61.19% |
|
38.28% |
|
$5.12M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
-- |
|
1.01 |
|
89.44 |
|
|
Return on Equity |
-18.78% |
-18.62% |
|
9.38% |
|
24.29% |
|
$-1.32 |
|
$0.03 |
|
$0.03 |
|